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ng, and interventions to prevent perinatal transmission of HIV, at
SS Hospital, Mysore.
Methods: All women attending antenatal clinics of the hos-
ital from October 2002 to December 2010 were counseled and
ubjected to HIV testing after an informed consent. Those found
ositive, were conﬁrmed to be seropositive, by two more rapid
ests. Such women were given SDNVP (200mg) at the onset of
abour.Ceasarian delivery was carried out with universal precau-
ions. Neonate was administered SDNVP (2mg/kg body weight)
t birth. Exclusive breast feeding was advised, baby followed up.
ested at 18 months of age by rapid tests for HIV.
Results: Out of 21003 women tested, 71 were conﬁrmed posi-
ive. 46 (65%) patients delivered in our hospital. 30 patients were
ollowed up for up to 18 months. None of these babies were
eropositive at 18 months.
Conclusion: The intervention in PPTCT to signiﬁcantly reduce
erinatal transmission of HIV can be successful if guidelines are
ollowed strictly and if the services are integrated with Maternal
nd Child Health services of the hospitals.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.748
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oles of mixing of drug-use network and sexual network on
eterosexual transmission of HIV among young drug users: an
gocentric network study in Yunnan, China
. Liu1,∗, J. Li 2, J. Li 1
Virginia Commonwealth University, Richmond, VA, USA
Yunnan Institute for Drug Abuse, Kunming, China
Background: The heterosexually transmitted HIV infection rate
s rapidly increasing among young drug users in China. HIV trans-
ission may be inﬂuenced by mixing of drug-use network and
exual network characteristics.
Methods: A community-based survey was conducted in Yun-
an, China, in which respondent-driving sampling (RDS) was used
o sample heroin users who were 18-35 years old. Using an ego-
entric social network questionnaire, we deﬁned two types of
etworks: drug use network and sexual network. Respondents
ere deﬁned as having mixing networks if they reported having
ad both a sexual network and a drug-use network.
Results: Among 426 respondents, 242 reported having had
ixing of both sexual network and drug-use network. The RDS-
djusted proportion of respondents having mixing networks was
6%. Among those who had mixing networks, 26% reported hav-
ng had both injection drug using (IDU) peers and non-injection
rug using (NIDU) peers, and 32% having had both regular and
on-regular sexual partners in their networks. Compared to those
ithout mixing networks, respondents with mixing were more
ikely to engage in risks forHIV infection. Speciﬁcally,more respon-
ents with mixing networks than those without reported having
ad (1) 2-3 sexual partners (31% vs. 20%), (2) both regular and
on-regular sexual partners (26% vs. 21%), (3) concurrent sexual
artnerships (52% vs. 40%), (4) IDU network peers (79% vs. 30%),
nd (6) NIDU peers in their network (48% vs. 33%). Consistent con-
om use with regular or non-regular partners was low in the two
roups, between 18% and 46%. The risk of parenteral transmissionfectious Diseases 16S (2012) e158–e316
of HIV was relatively low. Measured over life time, only about 2%
of drug users with or without mixing networks shared needles for
half or more episodes of injecting. Over the last 30 days, only 8% of
drug users with mixing networks and 4% of those without had ever
sheared them with others.
Conclusion: The ﬁndings of this study document that het-
erosexual HIV transmission can be driven by mixing patterns of
drug-use network and sexual network and the generalization of
the HIV epidemic from high-risk groups to the general population.
Effective intervention programs should take the characteristics of
mixing into consideration.
http://dx.doi.org/10.1016/j.ijid.2012.05.749
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Factors inﬂuencing the initiation of antiretroviral therapy in
HIV infected patients attending the Bamenda and the Bertoua
regional treatment centers in Cameroon
F.-X.Mbopi-Keou1,∗, E. Voundi Voundi2, I. Emah3, F. Angwafo III 1,
W. Muna1
1 Ministry of Health & University of Yaounde I, Yaounde, Cameroon
2 Ministry of Health, Bertoua, Cameroon
3 Ministry of Health, Yaounde, Cameroon
Background: In sub-Saharan Africa, access to antiretroviral
drugs (ARVs) remains low due to various obstacles. Encouraging
progress in the availability of these drugs in Cameroon has been
noted leading to an increase number of treatment centers and an
increase number of patients under ARVs. The present study aimed
at determining the factors inﬂuencing the initiation of ARV therapy
in HIV infected patients attending the Bamenda and the Bertoua
regional treatment centers in Cameroon (RTC).
Methods: A cross sectional study involving 460 ﬁles of HIV
infected adult patients attending the Bamenda and the Bertoua RTC
was carried out from January to April 2011. Socio-demographic,
biological and clinical characteristics including the antiretroviral
treatment were compared between these RTC. Data were analysed
using the Chi-Squared and the Ficher, and statistical signiﬁcance
was set at p <0.05.
Results: Out of the 460 ﬁles, 53.9% were from Bamenda and
46.1% from Bertoua RTC. The median age of patients was 36 years
in Bamenda and 35 years in Bertoua. There were more female
patients in both the Bamenda (69, 0%) and the Bertoua (61, 8%)
RTC (p=0.11). The majority of patients in Bertoua discovered their
HIV status through voluntary testing as compared to those in
Bamenda (41 vs 22; p=0.008). HIV type 1 and 2 viruses were
more frequent in Bamenda than in Bertoua (15 vs 3; p=0.011).
The median CD4 count was 133 cells/mm3 in Bamenda and 175
cell/mm3 in Bertoua (p=0.008). Standard ﬁrst line ARV drugs were
the most used protocols [Bamenda (93.1%) and Bertoua (98.1)].
Zidovudine, Nevirapine and Lopinavir were more frequently used
in Bamenda (p=0.000), while Tenofovir and Effavirenz were more
used in Bertoua (p=0.017).Conclusion: This study highlights the fact that socio-
demographic, biological and clinical management of patients differ
from one RTC to the other in Cameroon, even when both have a
high HIV prevalence. We therefore recommend the standardiza-
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ment systems, M&E systems, donor ﬂexibility, partnerships have
to be in place and have to work.
http://dx.doi.org/10.1016/j.ijid.2012.05.75215th ICID Abstracts / International Journa
ion of treatment strategies according to national HIV treatment
uidelines. In addition to education programs for behaviour change
owards HIV/AIDS, future studies should focus in the comparison
f the management options for HIV infection in the different treat-
ent centers throughout Cameroon.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.750
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case report: Rapid improvement of neurological symptoms
ollowing antiretroviral therapy in HIV encephalopathy pre-
enting as hydrocephalus
. Miki ∗, H. Oka
Kanto Rosai Hospital, Kawasaki, Japan
Background:Neurologic disorders associatedwithHIV consists
f two principal groups. One group is the opportunistic infections,
nd the other is the primary HIV encephalopathy. The diagnosis is
ne of exclusion, and neurologic disorders including opportunistic
nfectionofCNSbeforeHIVencephalopathy isdiagnosed.Wereport
rare case of HIV encephalopathy in which evaluation of subacute
onobstructive hydrocephalus, led to the initial diagnosis of HIV-1
nfection.
Methods:Patient presentation: A44year old previously healthy
an presented with a two month history of increasing gait dif-
culties, memory dysfunctions and alalia. A brain MRI revealed
nlarged ventricles without any white matter abnormal signals.
SF was abnormal with lymphocytic pleocytosis of 193 cells/mm3,
ncreasedprotein countof 166mg/dl andnormal glucose count. The
ause of the hydrocephalus and the pleocytosis remained unclear,
ut during this evaluation a borderline leucopenia (3.900 cells/
m3) and his homosexual activity prompted HIV testing. A HIV-
antibody test was positive with a serum viral load of 150,000
opies/ mm3 and his CD4-cell count was 145.
Results:Based on the clinical presentation, the diagnosis of sub-
cute meningitis was made. Subsequent CSF showed concurrent
pportunistic infection of CNS, but serum testing for cryptococ-
us, CMV, toxoplasmosis, treponema palllidum, and fungi were
egative. There was no radiological or cytological evidence of CNS
ymphoma.Apresumptivediagnosisof tuberculosismeningitiswas
ade, and treatment with ﬁrst line anti-TB drugs commenced.
wo months after the initiation of anti-TB therapy his neurocog-
itive impairment continued. The presence of CSF pleocytosis was
hought to reﬂect inﬂammatory component in HIV encephalopa-
hy. The patient was then started on combination antiretroviral
herapy (ART). A dramatic clinical improvement occurred within
few weeks since beginning ART. Improvement of neurocognitive
unctionwas paralleled by a decline in CSF andplasma serumHIV-1
NA levels.
Conclusion: CSF pleocytosis without any abnormal radiologi-
al image can occur in an unusual form of HIV encephalopathy. If
tudies for HIV-related opportunistic neurological infections were
egative, HIV encephalopathymust be suspected in hydrocepharus
ith pleocytosis in cerebrospinal ﬂuid. The initiation of ART is the
nly way to improve patient’s neurocognitive impairment.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.751fectious Diseases 16S (2012) e158–e316 e187
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Managing the anti-retroviral therapy supply chain of Inter Reli-
gious Council of Uganda (IRCU) with leveled funding for ﬁve
years
S.M. Nakaggwa
Inter - Religious Council Of Uganda, Kampala, Uganda
Background: In Uganda, it is estimated that about 180,974 of
the 357,000 patients estimated to be in need of ART are accessing
it (MOH 2009). Inter-Religious Council of Uganda (IRCU) is a Faith
Based Organization offering palliative care and ART services to 19
Faith BasedHealth facilities (FBOs) using the Faith Based Approach.
Anti-Retroviral Drugs (ARVs) are some of the supplies which IRCU
provides to the FBOs. An assessment was done to determine the
means of scaling up clients on ART with the leveled funds from
USAID (2010 – 2014).
Methods: This was a situational analysis which was both qual-
itative and quantitative so as to give strategic direction to the
organisation’s HIV/AIDS program. IRCU management, senior reli-
gious leaders in Uganda, donors and partners were involved in
consultations/assessment which was aimed at determining ways
of scaling up IRCU HIV/AIDS program with levelled funds.
Results: Services offered by FBOs areHCT (19), HBC (18), septrin
prophylaxis (19), treatment of OIs (17), TB/HIV (15), PMTCT (14),
sexual reproductive health (16), Paediatric & adult ART services
(14). Changing from branded to generic medicines to save costs in
procurement; use of MOH treatment guidelines by all FBOs; main-
taining most clients on ﬁrst line regimen; integration by working
with MOH systems at FBO sites to reduce on infrastructure, human
resource and systems costs; Partnership with other organizations
to foster continuum of services; regular training, mentoring and
couching for health workers; and also involving PHLAs in service
delivery. As a result, 12,069 clients are on ART and of these 98% are
on ﬁrst line regimens.
Conclusion: Inorder toachieve scaleupwithin the limited fund-
ing, a variety of factors namely:market prices, staff training, an
effective and efﬁcient drugs logistics and supply chain manage-
